‡ In these countries please contact our distributor


DURAFIBER Ag Instructions for use


DURAFIBER Ag is an absorbent, non-woven, silver containing antimicrobial dressing composed of cellulose ethyl sulphonate fibres. The ionic silver in the dressing provides antimicrobial activity against a broad spectrum of common wound pathogens which may help to reduce bacterial bioburden and the risk of infection17.

DURAFIBER Ag is designed to rapidly form a clear cool gel on contact with wound fluid. This gel absorbs excess fluid, locks exudate away from the wound4, provides a moist environment to support autolytic debridement21 and conforms intimately to the wound bed5. The high integral wet strength of DURAFIBER Ag facilitates easy one-piece removal from moist wound beds and cavity wounds4 so minimising trauma to the wound and pain to the patient on removal4.

DURAFIBER Ag can be use in conjunction with a range of cover dressings including ALLEVYN* and PROFORE. DURAFIBER Ag may also be used with OPSITE* on lightly exuding wounds. 


DURAFIBER Ag is indicated as an absorbent, antimicrobial gelling dressing for the management of chronic and acute, full thickness, partial thickness, or shallow granulating exuding wounds. For example: leg ulcers; pressure ulcers; diabetic ulcers; surgical wounds; traumatic wounds; donor sites; partial thickness burns; tunnelling and fistulae wounds; wounds left to heal by secondary intent; and wounds that are prone to bleeding such as wounds that have been surgically or mechanically debrided.

DURAFIBER Ag is designed to be left in place for up to 7 days.

DURAFIBER Ag may be used on infected wounds. Where the product is used on infected wounds the infection should be inspected and treated as per local protocol.


Do not use on patients with a known sensitivity to silver. Do not use on non-exuding wounds.

  • Clinicians/Healthcare Professionals should be aware that there are very limited data on prolonged and repeated use of silver containing dressings, particularly in children and neonates.

  • Whilst DURAFIBER Ag assists in the management of wounds prone to minor bleeding, it is not intended to be used as a surgical sponge in heavily bleeding wounds.

  • DURAFIBER Ag is not compatible with oil-based products such as petrolatum.

  • Avoid contact with electrodes or conductive gels during electronic measurements e.g. EEG and ECG.

  • Ensure that packing in cavities sinuses etc. has been removed.

  • The dressing may not be compatible with topical antimicrobials.

  • If reddening or sensitisation occurs discontinue use.

  • In the event of clinical infection, topical silver does not replace the need for systemic therapy or other adequate infection treatment.

  • When DURAFIBER Ag is used on a patient during MRI (Magnetic Resonance Imaging) examination some warming may be experienced.

  • DURAFIBER Ag may cause transient discoloration of the surrounding skin.

Instructions for Use
  1. Cleanse the wound according to local clinical protocol.

  2. Select appropriate dressing size.

  3. Remove the DURAFIBER Ag dressing from pack, using a clean technique. Cut to shape if necessary.

  4. Apply the dressing to the wound and allow for a 1cm / 1/3in.dressing overlap onto the skin surrounding the wound.

  5. When using DURAFIBER Ag in deep cavity wounds use whole dressings where possible and leave at least 2.5cm / 1in. of each piece outside the wound for easy retrieval.

  6. Loosely pack deep wounds up to 80% capacity, as DURAFIBER Ag will expand on contact with wound fluid.

  7. Secure DURAFIBER Ag with a moisture retentive dressing (e.g. ALLEVYN/OPSITE) or other appropriate secondary retention.

  8. The dressing can be removed in one piece using sterile tweezers, forceps or a gloved hand.

  9. The dressing may adhere if used on lightly exuding wounds. If the dressing is not easily removed, moisten or soak the dressing in sterile saline to assist removal and avoid disruption of the healing wound.

Frequency of change 

During the early stages of wound management, DURAFIBER dressings should be inspected frequently. Dressings can be left undisturbed for up to 7 days or changed when clinically indicated, (e.g. if leakage, excessive bleeding is present). Local clinical protocol should also be taken into consideration. DURAFIBER Ag is a single use product. If used on more than one patient, cross-contamination or infection may result. Opening the dressing pack compromises the sterile barrier. Any unused dressing should be discarded.